1. The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen
   Nan Geng et al, 2021, Technology in Cancer Research & Treatment CrossRef
2. Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment
   Ming Bai et al, 2021, International Journal of General Medicine CrossRef
3. Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Epithelial Ovarian Cancer: A Retrospective Study
   Xiao-Yuan Li et al, 2022, International Journal of General Medicine CrossRef
4. Implication of VEGFR2 Polymorphism on the Prognosis of Anlotinib Monotherapy for Patients With Treatment-Refractory Advanced NSCLC: An Exploratory Study
   Xiaoyuan Li et al, 2022, Technology in Cancer Research & Treatment CrossRef
5. Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
   Xiongjie Jia et al, 2023, Pharmacogenomics and Personalized Medicine CrossRef
6. Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
   Lei Meng et al, 2023, Pharmacogenomics and Personalized Medicine CrossRef